If your doctor checks your blood sugar, they typically order one of two tests: fasting glucose or HbA1c. Some order both. Most order just one. The question is whether one is enough — and the answer, if you care about catching metabolic problems early, is no.

What each test measures

Fasting glucose is a snapshot. It tells you what your blood sugar level is right now, after at least 8 hours without eating. Normal is under 100 mg/dL. Between 100 and 125 is prediabetes. Above 126 is diabetes.

HbA1c (glycated hemoglobin) is a 3-month average. It measures the percentage of your hemoglobin molecules that have glucose permanently attached to them. Because red blood cells live for about 3 months, HbA1c reflects your average blood sugar over that entire period. Normal is under 5.7%. Between 5.7% and 6.4% is prediabetes. Above 6.5% is diabetes.

Both tests are useful. Neither alone is sufficient.

Where fasting glucose fails

Fasting glucose is measured at a single point in time. Your blood sugar at 7 AM on a Tuesday depends on what you ate the night before, how well you slept, your stress level, whether you exercised yesterday, and whether your liver decided to dump a bunch of stored glucose overnight (the "dawn phenomenon").

A person with early insulin resistance can have a fasting glucose of 92 one day and 108 the next. The first result is "normal." The second is "prediabetes." Same person, same metabolism — just biological noise.

Fasting glucose also misses postprandial hyperglycemia — the blood sugar spikes that happen after meals. Some people have normal fasting glucose but wildly abnormal glucose responses to food. Fasting glucose can't see this.

Where HbA1c fails

HbA1c smooths out the noise that fasting glucose is vulnerable to — which is its strength. But it has blind spots of its own.

HbA1c can be misleading in people with conditions that affect red blood cell lifespan: iron deficiency anemia (artificially high HbA1c), hemoglobin variants (common in African American, Mediterranean, and Southeast Asian populations), recent blood transfusions, or chronic kidney disease.

It can also miss early-stage insulin resistance. Because HbA1c is an average, it can look normal even when post-meal glucose spikes are frequent — as long as the fasting glucose between meals brings the average back down.

Why we use both — plus insulin

At Health Detectors, the DETECT panel includes fasting glucose, HbA1c, and fasting insulin. The third marker is the one most programs miss — and it's the most important for early detection.

Fasting insulin, combined with fasting glucose to calculate HOMA-IR, detects insulin resistance 5 to 15 years before glucose or HbA1c become abnormal. It's the early warning system that the other two tests lack.

Together, the three markers cover different time horizons and different failure modes:

  • Fasting insulin/HOMA-IR: years -15 to -5. Detects the earliest stage of metabolic dysfunction.
  • HbA1c: months -3 to now. Detects sustained glycemic elevation. Catches what fasting glucose misses on a bad day.
  • Fasting glucose: right now. Provides the standard diagnostic criterion and tracks acute changes.

The bottom line

Neither fasting glucose nor HbA1c alone is sufficient for meaningful metabolic screening. Together with fasting insulin, they cover the full spectrum from early insulin resistance to frank diabetes. Leaving any one of them out means accepting a blind spot in your metabolic picture.

References

  1. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2024;47(Suppl 1).
  2. Tabák AG, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes (Whitehall II). Lancet. 2009;373(9682):2215-2221.
  3. Herman WH, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance (DPP). Diabetes Care. 2007;30(10):2453-2457.